Xeris Biopharma Holdings, Inc. (XERS)
5.42
-0.19
(-3.39%)
USD |
NASDAQ |
Mar 18, 15:59
5.43
+0.01
(+0.18%)
After-Hours: 17:02
Xeris Biopharma Holdings Profit Margin (Quarterly) : 12.91% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 11.83% |
| Zoetis, Inc. | 25.26% |
| Harrow, Inc. | 7.44% |
| Zymeworks, Inc. | -1.64K% |
| Vir Biotechnology, Inc. | -66.99% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | 0.16% |
| Return on Invested Capital | 0.22% |
| Gross Profit Margin (Quarterly) | 84.08% |
| Operating Margin (Quarterly) | 19.55% |
| Return on Net Operating Assets | 0.22% |